Legal & General Group
EXEL icon

Legal & General Group’s Exelixis EXEL Stock Holding History

Legal & General Group’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17M Sell
395,298
-38,560
-9% -$1.66M ﹤0.01% 892
2025
Q4 		$19M Sell
433,858
-110,542
-20% -$4.57M ﹤0.01% 870
2025
Q3 		$22.5M Sell
544,400
-37,434
-6% -$1.5M 0.01% 821
2025
Q2 		$25.6M Sell
581,834
-572
-0.1% -$22.9K 0.01% 768
2025
Q1 		$21.5M Buy
582,406
+6,348
+1% +$226K 0.01% 783
2024
Q4 		$19.2M Sell
576,058
-1,735
-0.3% -$56.3K 0.01% 843
2024
Q3 		$15M Sell
577,793
-17,436
-3% -$433K ﹤0.01% 960
2024
Q2 		$13.4M Sell
595,229
-79,823
-12% -$1.77M ﹤0.01% 980
2024
Q1 		$16M Sell
675,052
-55,815
-8% -$1.24M ﹤0.01% 918
2023
Q4 		$17.5M Sell
730,867
-19,645
-3% -$427K 0.01% 881
2023
Q3 		$16.4M Sell
750,512
-26,220
-3% -$548K 0.01% 879
2023
Q2 		$14.8M Sell
776,732
-31,681
-4% -$611K ﹤0.01% 931
2023
Q1 		$15.7M Buy
808,413
+26,474
+3% +$461K 0.01% 880
2022
Q4 		$12.5M Buy
781,939
+10,813
+1% +$176K ﹤0.01% 959
2022
Q3 		$12.1M Buy
771,126
+2,965
+0.4% +$57.3K ﹤0.01% 953
2022
Q2 		$16M Buy
768,161
+60,994
+9% +$1.26M 0.01% 884
2022
Q1 		$16M Buy
707,167
+10,504
+2% +$205K ﹤0.01% 945
2021
Q4 		$12.7M Sell
696,663
-13,144
-2% -$252K ﹤0.01% 1082
2021
Q3 		$15M Buy
709,807
+52,874
+8% +$982K ﹤0.01% 995
2021
Q2 		$12M Sell
656,933
-60,745
-8% -$1.42M ﹤0.01% 1078
2021
Q1 		$16.2M Buy
717,678
+12,686
+2% +$286K 0.01% 955
2020
Q4 		$14.1M Sell
704,992
-20,153
-3% -$422K 0.01% 954
2020
Q3 		$17.7M Buy
725,145
+17,380
+2% +$406K 0.01% 825
2020
Q2 		$16.8M Buy
707,765
+266,516
+60% +$6.18M 0.01% 831
2020
Q1 		$7.6M Buy
441,249
+2,751
+0.6% +$50.3K ﹤0.01% 989
2019
Q4 		$7.73M Buy
438,498
+38,983
+10% +$661K ﹤0.01% 1141
2019
Q3 		$7.07M Buy
399,515
+31,727
+9% +$642K ﹤0.01% 1122
2019
Q2 		$7.86M Buy
367,788
+18,635
+5% +$391K ﹤0.01% 1060
2019
Q1 		$8.31M Buy
349,153
+3,973
+1% +$90.6K ﹤0.01% 943
2018
Q4 		$6.79M Buy
345,180
+18,567
+6% +$331K 0.01% 940
2018
Q3 		$5.79M Buy
326,613
+16,918
+5% +$330K ﹤0.01% 1087
2018
Q2 		$6.67M Buy
309,695
+151,752
+96% +$3.14M 0.01% 993
2018
Q1 		$3.5M Buy
157,943
+2,280
+1% +$63K ﹤0.01% 1305
2017
Q4 		$4.73M Buy
155,663
+30,328
+24% +$807K ﹤0.01% 1125
2017
Q3 		$3.04M Buy
125,335
+19,260
+18% +$513K ﹤0.01% 1341
2017
Q2 		$2.61M Buy
106,075
+21,312
+25% +$451K ﹤0.01% 1379
2017
Q1 		$1.83M Buy
84,763
+1,078
+1% +$21.9K ﹤0.01% 1527
2016
Q4 		$1.25M Buy
83,685
+32,466
+63% +$468K ﹤0.01% 1655
2016
Q3 		$642K Buy
51,219
+10,222
+25% +$111K ﹤0.01% 1588
2016
Q2 		$319K Buy
40,997
+7,500
+22% +$43.2K ﹤0.01% 1581
2016
Q1 		$136K Buy
33,497
+3,440
+11% +$14.6K ﹤0.01% 1884
2015
Q4 		$171K Hold
30,057
– – ﹤0.01% 1809
2015
Q3 		$173K Hold
30,057
– – ﹤0.01% 1771
2015
Q2 		$108K Hold
30,057
– – ﹤0.01% 2044
2015
Q1 		$80K Hold
30,057
– – ﹤0.01% 2186
2014
Q4 		$41K Hold
30,057
– – ﹤0.01% 2520
2014
Q3 		$47K Buy
+30,057
New +$96.5K ﹤0.01% 2414

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Legal & General Group's EXEL Position: Q1 2026 in Review

Legal & General Group reduced its Exelixis (EXEL) stake by 8.9% in Q1 2026, selling an estimated $1.66M and leaving 395,298 shares worth $17M. The position accounts for ﹤0.01% of the portfolio, ranked #892.

Legal & General Group first reported a position in EXEL in Q3 2014 and has held it in 47 quarters since. The position peaked at $25.6M in Q2 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Legal & General Group held 395,298 shares of Exelixis worth $17M as of Q1 2026.
  • Legal & General Group sold 38,560 Exelixis shares in Q1 2026, an estimated $1.66M.
  • Exelixis made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #892 holding.
  • Legal & General Group first reported a position in Exelixis in Q3 2014 and has held it in 47 quarters since.
  • Legal & General Group's Exelixis position peaked at $25.6M in Q2 2025.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.